Greg Harrison Analyst Performance

Analyst at Bank of America

Greg Harrison is a stock analyst at Bank of America in the medical sector, covering 16 publicly traded companies. Over the past year, Greg Harrison has issued 28 stock ratings, including buy and hold recommendations. While full access to Greg Harrison's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Greg Harrison's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ranking: Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Success Rate: 00.00% Profitable Ratings
Total Ratings: 28 Last 0 Years
Buy Recommendations: 71.43% 20 Buy Ratings
Companies Covered: 16 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	71.4%	20 ratings
Hold	28.6%	8 ratings
Sell	0.0%	0 ratings

Out of 28 total stock ratings issued by Greg Harrison at Bank of America, the majority (71.4%) have been Buy recommendations, followed by 28.6% Hold.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	100.0% of companies on NASDAQ	16 companies

Greg Harrison, an analyst at Bank of America, currently covers 16 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 16 companies	100.0%

Greg Harrison of Bank of America specializes in stock coverage within the Medical sector.

Coverage Industries

Industry	Percentage
MED - BIOMED/GENE 13 companies	81.3%
MED - DRUGS 2 companies	12.5%
MED - GENERIC DRG 1 company	6.3%

Timeframe

Start Date

End Date

Rating

12-Month ROIAll ROI

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating
UTHR United Therapeutics	9/2/2025	Boost Price Target	$409.21	$463.00	Neutral
MLYS Mineralys Therapeutics	8/28/2025	Boost Price Target	$15.29	$43.00	Buy
RCKT Rocket Pharmaceuticals	8/20/2025	Upgrade	$3.66	$10.00	Buy
TVTX Travere Therapeutics	8/7/2025	Boost Price Target	$16.79	$31.00	Sector Outperform
OCUL Ocular Therapeutix	8/6/2025	Lower Price Target	$12.35	$20.00	Sector Outperform
BBIO BridgeBio Pharma	8/6/2025	Boost Price Target	$43.74	$57.00	Sector Outperform
VRTX Vertex Pharmaceuticals	8/5/2025	Lower Price Target	$392.94	$438.00	Sector Perform
ALNY Alnylam Pharmaceuticals	8/1/2025	Boost Price Target	$401.80	$450.00	Sector Outperform
AGIO Agios Pharmaceuticals	7/28/2025	Lower Price Target	$37.20	$65.00	Sector Outperform
RCKT Rocket Pharmaceuticals	7/25/2025	Reiterated Rating	$3.21	$4.00	Neutral
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
AGIO Agios Pharmaceuticals	7/22/2025	Lower Price Target	$39.54	$51.00	Buy
GOSS Gossamer Bio	7/14/2025	Initiated Coverage	$1.36	$11.00	Sector Outperform
UTHR United Therapeutics	6/11/2025	Lower Price Target	$278.95	$315.00	Neutral
VERA Vera Therapeutics	6/2/2025	Set Price Target	$30.98	$65.00	Sector Outperform
ARCT Arcturus Therapeutics	5/28/2025	Initiated Coverage	$11.87	$32.00	Sector Outperform
RCKT Rocket Pharmaceuticals	5/28/2025	Lower Price Target	$2.41	$19.00	Sector Outperform
LQDA Liquidia Technologies	5/28/2025	Boost Price Target	$14.70	$37.00	Sector Outperform
RCKT Rocket Pharmaceuticals	5/28/2025	Lower Price Target	$2.51	$9.00	Buy
RCKT Rocket Pharmaceuticals	5/12/2025	Lower Price Target	$7.16	$51.00	Sector Outperform
KROS Keros Therapeutics	5/12/2025	Lower Price Target	$13.52	$26.00	Sector Outperform
GERN Geron	5/8/2025	Downgrade	$1.31	$1.50	Sector Perform
APLS Apellis Pharmaceuticals	5/8/2025	Lower Price Target	$17.49	$20.00	Sector Perform
VRTX Vertex Pharmaceuticals	5/6/2025	Lower Price Target	$434.64	$442.00	Sector Perform
LQDA Liquidia Technologies	5/5/2025	Boost Price Target	$16.30	$36.00	Sector Outperform
AGIO Agios Pharmaceuticals	5/2/2025	Lower Price Target	$31.18	$71.00	Sector Outperform
BBIO BridgeBio Pharma	4/30/2025	Boost Price Target	$38.50	$55.00	Sector Outperform
UTHR United Therapeutics	4/21/2025	Upgrade	$284.73	$314.00	Neutral
TVTX Travere Therapeutics	4/1/2025	Boost Price Target	$17.92	$31.00	Buy

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.